Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictors of Rebound Hyperbilirubinemia After Phototherapy in Neonates

NCT07694635 is registered in ClinicalTrials.gov with Haseki Training and Research Hospital as lead sponsor.

NCT NCT07694635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07694635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictors of Rebound Hyperbilirubinemia After Phototherapy in Neonates
Lead sponsor
Haseki Training and Research Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
June 15, 2026
Completion date
November 30, 2026
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal hyperbilirubinemia, rebound hyperbilirubinemia